VIVA BIOTECH

Viva Biotech opened low at HK$1.210 in the morning session, quickly surged to an intraday high of HK$1.270, then fluctuated narrowly around HK$1.250 in the afternoon, closing up 5.93% at HK$1.250, ending a recent losing streak. The company's ongoing share repurchases for cancellation (e.g., at HK$1.12 per share), coupled with a 31.4% YoY jump in full-year 2025 net profit to RMB 220 million, offset a 6.63% revenue decline, while the net profit margin held steady at 10.91%, boosting sentiment. The stock remains 61.77% below its 52-week high of HK$3.27 and down 28.98% YTD, but has reclaimed its 20-day moving average of HK$1.157, though still below the 60-day MA of HK$1.464, indicating repaired short-term momentum but lingering medium-term headwinds. However, after-hours disclosure of 6.22 million RSUs granted to CDMO staff at HK$1.08 each could pose near-term dilution.